Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.

PubWeight™: 7.06‹?› | Rank: Top 1%

🔗 View Article (PMID 22731672)

Published in N Engl J Med on June 25, 2012

Authors

Erik K Alexander1, Giulia C Kennedy, Zubair W Baloch, Edmund S Cibas, Darya Chudova, James Diggans, Lyssa Friedman, Richard T Kloos, Virginia A LiVolsi, Susan J Mandel, Stephen S Raab, Juan Rosai, David L Steward, P Sean Walsh, Jonathan I Wilde, Martha A Zeiger, Richard B Lanman, Bryan R Haugen

Author Affiliations

1: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. ekalexander@partners.org

Associated clinical trials:

Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules | NCT02681328

Validation of a Multi-Genetic Test for the Diagnosis of Indeterminate Thyroid Nodules (CT-DS) | NCT03061318

Articles citing this

(truncated to the top 100)

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid (2016) 12.86

Integrated genomic characterization of papillary thyroid carcinoma. Cell (2014) 6.05

Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer (2013) 4.46

Progress in molecular-based management of differentiated thyroid cancer. Lancet (2013) 2.44

Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest (2014) 2.39

Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab (2013) 2.34

Biologic and Clinical Perspectives on Thyroid Cancer. N Engl J Med (2016) 2.15

Fine Needle Aspiration in the Investigation of Thyroid Nodules. Dtsch Arztebl Int (2016) 2.13

American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making. Thyroid (2015) 2.11

Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid (2014) 2.04

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid (2015) 1.42

A panel of four genes accurately differentiates benign from malignant thyroid nodules. J Exp Clin Cancer Res (2016) 1.40

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology. Thyroid (2015) 1.36

Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis. Diagn Pathol (2012) 1.36

The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology. Thyroid (2012) 1.34

Current status and future perspectives in differentiated thyroid cancer. Endocrinol Metab (Seoul) (2014) 1.29

A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer. N Engl J Med (2015) 1.22

Minimizing unnecessary surgery for thyroid nodules. N Engl J Med (2012) 1.19

New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin (2013) 1.16

Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat Rev Genet (2016) 1.12

Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review. BMC Surg (2013) 1.10

Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology. J Clin Endocrinol Metab (2015) 1.02

The Implementation of the Bethesda System for Reporting Thyroid Cytopathology Improves Malignancy Detection Despite Lower Rate of Thyroidectomy in Indeterminate Nodules. World J Surg (2015) 1.01

Prognostic biomarkers in thyroid cancer. Virchows Arch (2014) 0.95

Molecular approaches to thyroid cancer diagnosis. Endocr Relat Cancer (2014) 0.93

Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules. Ann Surg Oncol (2015) 0.91

Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients. BMC Surg (2013) 0.91

The variable phenotype and low-risk nature of RAS-positive thyroid nodules. BMC Med (2015) 0.89

Nodular goiter with amyloid deposition in an elderly patient: fine-needle cytology diagnosis and review of the literature. BMC Surg (2013) 0.87

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process. Rambam Maimonides Med J (2016) 0.86

Integrative metabonomics as potential method for diagnosis of thyroid malignancy. Sci Rep (2015) 0.86

Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy. Endocr Relat Cancer (2014) 0.85

Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients. BMC Surg (2013) 0.85

Utilization and impact of repeat biopsy for follicular lesion/atypia of undetermined significance. World J Surg (2014) 0.83

Progress and potential: training in genomic pathology. Arch Pathol Lab Med (2014) 0.83

The Mcgill thyroid nodule score - does it help with indeterminate thyroid nodules? J Otolaryngol Head Neck Surg (2015) 0.82

Early cytological diagnosis of extranodal stage I, primary thyroid Non-Hodgkin lymphoma in elderly patients. Report of two cases and review of the literature. BMC Surg (2013) 0.82

Thyroid fine-needle aspiration cytology: performance data of neoplastic and malignant cases as identified from 1558 responses in the ASCP Non-GYN Assessment program thyroid fine-needle performance data. Cancer Cytopathol (2014) 0.82

Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues. BMC Med Genomics (2013) 0.81

Translational research in endocrine surgery. Surg Oncol Clin N Am (2013) 0.81

Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer. BMC Med (2016) 0.81

A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma. World J Surg (2015) 0.81

Outcome of Subclassification of Indeterminate (Thy-3) Thyroid Cytology into Thy-3a and Thy-3f. Eur Thyroid J (2015) 0.79

Afirma Benign Thyroid Nodules Show Similar Growth to Cytologically Benign Nodules During Follow-Up. J Clin Endocrinol Metab (2015) 0.79

Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysis. Oncotarget (2015) 0.79

Potential effects of molecular testing of indeterminate thyroid nodule fine needle aspiration biopsy on thyroidectomy volume. World J Surg (2014) 0.79

The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes. BMC Bioinformatics (2016) 0.79

Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques. Cancer Med (2016) 0.79

Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation. Ann Surg Oncol (2013) 0.79

Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis. Thyroid (2015) 0.79

Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis. Int J Mol Sci (2017) 0.78

Follicular nodules (Thy3) of the thyroid: is total thyroidectomy the best option? BMC Surg (2014) 0.78

Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer. Endocrinology (2013) 0.78

Core Needle Biopsy of the Thyroid: 2016 Consensus Statement and Recommendations from Korean Society of Thyroid Radiology. Korean J Radiol (2017) 0.78

P53 and expression of immunological markers may identify early stage thyroid tumors. Clin Dev Immunol (2013) 0.78

The Profile of Heparanase Expression Distinguishes Differentiated Thyroid Carcinoma from Benign Neoplasms. PLoS One (2015) 0.78

Use of the afirma® gene expression classifier for preoperative identification of benign thyroid nodules with indeterminate fine needle aspiration cytopathology. PLoS Curr (2013) 0.78

The surgical management of thyroid cancer. Rambam Maimonides Med J (2014) 0.78

Role of metallothioneins in benign and malignant thyroid lesions. Thyroid Res (2012) 0.78

Molecular classification of thyroid lesions by combined testing for miRNA gene expression and somatic gene alterations. J Pathol Clin Res (2016) 0.78

Does bethesda category predict aggressive features in malignant thyroid nodules? Ann Surg Oncol (2013) 0.78

Fine Needle Aspiration of Thyroid Nodules Using the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience in a Rural Setting. Int J Endocrinol (2017) 0.78

Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making. Mol Imaging Radionucl Ther (2016) 0.78

Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison. Eur J Nucl Med Mol Imaging (2015) 0.77

Local molecular analysis of indeterminate thyroid nodules. J Otolaryngol Head Neck Surg (2015) 0.77

Thyroid nodules with indeterminate cytology: molecular imaging with ⁹⁹mTc-methoxyisobutylisonitrile (MIBI) is more cost-effective than the Afirma gene expression classifier. Eur J Nucl Med Mol Imaging (2014) 0.77

Cytological diagnosis of adult-type fibrosarcoma of the neck in an elderly patient. Report of one case and review of the literature. BMC Surg (2013) 0.77

Evolutionary features of thyroid cancer in patients with thyroidectomies from 2008 to 2013 in China. Sci Rep (2016) 0.77

The final outcome of indeterminate cytology of thyroid nodules in a District General Hospital. G Chir (2015) 0.77

Cytopathologic diagnosis of fine needle aspiration biopsies of thyroid nodules. World J Clin Cases (2016) 0.77

A Pilot Study of Galectin-3, HBME-1, and p27 Triple Immunostaining Pattern for Diagnosis of Indeterminate Thyroid Nodules in Cytology With Correlation to Histology. Appl Immunohistochem Mol Morphol (2015) 0.76

Analytical validity of a microRNA-based assay for diagnosing indeterminate thyroid FNA smears from routinely prepared cytology slides. Cancer Cytopathol (2016) 0.76

Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears. J Clin Pathol (2016) 0.76

Response to Letter to the Editor on COI for American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules. Thyroid (2015) 0.75

Thyroid nodules with indeterminate cytology. N Engl J Med (2012) 0.75

Hürthle cell carcinoma: current perspectives. Onco Targets Ther (2016) 0.75

The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology. PLoS One (2015) 0.75

Metabolomic analysis of percutaneous fine-needle aspiration specimens of thyroid nodules: Potential application for the preoperative diagnosis of thyroid cancer. Sci Rep (2016) 0.75

Prevalence of Cancer in Patients with Thyroid Nodules in the Island of Cyprus: Predictive Value of Ultrasound Features and Thyroid Autoimmune Status. Eur Thyroid J (2015) 0.75

Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy. Sci Rep (2016) 0.75

A prospective cohort study to assess the role of FDG-PET in differentiating benign and malignant follicular neoplasms. Ann Med Surg (Lond) (2016) 0.75

Genetic Testing in Differentiated Thyroid Carcinoma: Indications and Clinical Implications. Rambam Maimonides Med J (2016) 0.75

Expression profile based gene clusters for ischemic stroke detection. Genomics (2014) 0.75

Cancer: Indeterminate thyroid nodules--added testing, added value? Nat Rev Endocrinol (2013) 0.75

A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology. Thyroid (2016) 0.75

Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer. PLoS One (2016) 0.75

Thyroid nodules with indeterminate cytology. N Engl J Med (2012) 0.75

A benign genomic classifier for thyroid nodules with indeterminate cytology: a critical appraisal. Gland Surg (2012) 0.75

Differential expression of transforming growth factor-beta in benign vs. papillary thyroid cancer nodules; a potential diagnostic tool? J Otolaryngol Head Neck Surg (2014) 0.75

Utility of Diagnostic Molecular Markers for Evaluation of Indeterminate Thyroid Nodules. JAMA Otolaryngol Head Neck Surg (2016) 0.75

Promise and pitfalls of molecular markers of thyroid nodules. Indian J Endocrinol Metab (2012) 0.75

Utility of molecular tests in cytopathology. Cytojournal (2014) 0.75

Preoperative diagnosis of benign thyroid nodules with intermediate cytology. Gland Surg (2012) 0.75

Survey of cytopathologists and cytotechnologists for the clinical impact of the use of atypia or follicular lesion of undetermined significance. Cytojournal (2015) 0.75

Diagnosis: test spots low-risk thyroid nodules. Nat Rev Endocrinol (2012) 0.75

Thyroid nodules with indeterminate cytology. N Engl J Med (2012) 0.75

Hurthle Cell Lesion: Controversies, Challenges, and Debates. Indian J Surg (2015) 0.75

Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker? Med Sci Monit (2015) 0.75

Update in endocrinology: evidence published in 2012. Ann Intern Med (2013) 0.75

Thyroid in 2012: Advances in thyroid development, hormone action and neoplasia. Nat Rev Endocrinol (2013) 0.75

Articles by these authors

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2006) 12.23

A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res (2005) 11.02

Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid (2009) 10.20

Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods (2004) 9.52

The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A (2005) 8.60

Mapping human genetic diversity in Asia. Science (2009) 7.40

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab (2008) 5.94

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA (2013) 5.71

Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res (2004) 5.59

Phase II trial of sorafenib in advanced thyroid cancer. J Clin Oncol (2008) 5.31

Dynamic model based algorithms for screening and genotyping over 100 K SNPs on oligonucleotide microarrays. Bioinformatics (2005) 5.01

Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology (2005) 4.96

Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am J Hum Genet (2004) 4.76

Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2007) 4.66

Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2012) 4.64

American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract (2006) 4.62

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab (2005) 4.39

Sclerosing angiomatoid nodular transformation (SANT): report of 25 cases of a distinctive benign splenic lesion. Am J Surg Pathol (2004) 4.36

Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol (2005) 3.99

A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell (2007) 3.97

A second-generation combined linkage physical map of the human genome. Genome Res (2007) 3.60

The genomic distribution of population substructure in four populations using 8,525 autosomal SNPs. Hum Genomics (2004) 3.53

Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab (2006) 3.50

Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer (2007) 3.36

Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol (2008) 3.30

Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet (2006) 3.29

A non-genetic route to aneuploidy in human cancers. Nat Cell Biol (2011) 3.25

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab (2009) 3.23

Description of the data from the Collaborative Study on the Genetics of Alcoholism (COGA) and single-nucleotide polymorphism genotyping for Genetic Analysis Workshop 14. BMC Genet (2005) 3.04

Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid (2006) 3.03

Upper-airway stimulation for obstructive sleep apnea. N Engl J Med (2014) 2.98

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol (2010) 2.96

Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol (2010) 2.86

Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol (2007) 2.75

Algorithms for large-scale genotyping microarrays. Bioinformatics (2003) 2.66

Progress in molecular-based management of differentiated thyroid cancer. Lancet (2013) 2.44

High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs. Am J Hum Genet (2005) 2.39

Papanicolaou tests diagnosed as atypical by a cytotechnologist and downgraded to benign by a pathologist: a measure of laboratory quality. Am J Clin Pathol (2002) 2.35

RE: population-level impact of the bivalent, quadrivalent, and candidate nonavalent human papillomavirus vaccines: a comparative model-based analysis. J Natl Cancer Inst (2013) 2.34

Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol (2002) 2.25

Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol (2008) 2.21

Proposal of a novel system for the staging of thymic epithelial tumors. Ann Thorac Surg (2005) 2.19

Papanicolaou screening in developing countries: an idea whose time has come. Am J Clin Pathol (2004) 2.18

Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol (2006) 2.15

The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract (2009) 2.14

Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis. Hum Pathol (2012) 2.09

Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol (2004) 2.08

Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res (2012) 2.06

Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer. J Nucl Med (2002) 2.05

The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal (2008) 2.05

Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg (2003) 2.05

Thyroid carcinoma. J Natl Compr Canc Netw (2010) 2.02

Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules? J Ultrasound Med (2003) 2.01

Interpretive Diagnostic Error Reduction in Surgical Pathology and Cytology: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center and the Association of Directors of Anatomic and Surgical Pathology. Arch Pathol Lab Med (2015) 2.01

Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab (2002) 1.91

Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid (2009) 1.90

Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol (2007) 1.89

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. J Nucl Med (2006) 1.86

Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery (2013) 1.85

The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid (2012) 1.82

Phi29 polymerase based random amplification of viral RNA as an alternative to random RT-PCR. BMC Mol Biol (2008) 1.81

Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet (2012) 1.81

Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab (2002) 1.76

Distinct genetic alterations in the mitogen-activated protein kinase pathway dictate sensitivity of thyroid cancer cells to mitogen-activated protein kinase kinase 1/2 inhibition. Thyroid (2009) 1.73

Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases. Diagn Cytopathol (2002) 1.71

Tumor-specific changes in mtDNA content in human cancer. Int J Cancer (2005) 1.70

A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid (2010) 1.68

The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol (2012) 1.68

Acute bacterial suppurative thyroiditis: a clinical review and expert opinion. Thyroid (2010) 1.65

A randomized trial of temperature-controlled radiofrequency, continuous positive airway pressure, and placebo for obstructive sleep apnea syndrome. Otolaryngol Head Neck Surg (2003) 1.65

Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab (2010) 1.65

Coming to terms with Vietnam: the Viet/American Cervical Cancer Prevention Project. Diagn Cytopathol (2005) 1.65

Current concepts on Riedel thyroiditis. Am J Clin Pathol (2004) 1.63

Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer (2004) 1.61

Review article: pulmonary sarcomatoid carcinomas: a practical overview. Int J Surg Pathol (2009) 1.61

Analytical performance verification of a molecular diagnostic for cytology-indeterminate thyroid nodules. J Clin Endocrinol Metab (2012) 1.60